“Clinical Efficacy of Rifampicin Nanoparticle Local Delivery in Post-Surgical Wound Infections Caused by Resistant Bacteria”, LMJHCR, vol. 3, no. 2, pp. 1–11, Dec. 2025, doi: 10.61919/xrpzj971.